New Zealand
Country
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Nearly 80 documents have been posted on the tracker since its last update.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.
Two targeted treatments for six different types of cancer and two antifungal drugs are the first products that Pharmac has proposed should be funded after it received a boost to its budget in June. Separately, the government is seeking feedback on a bill to repeal the sweeping new therapeutic products law that was passed by its predecessor.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
A revised pharmacovigilance guideline will come into effect in New Zealand on 1 July, although sponsors may start using it now.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
A parallel assessment mechanism that will allow new medicines in any therapeutic area to be considered for funding sooner is being introduced in New Zealand, where the new coalition government is working to repeal last year’s landmark Therapeutic Products Act.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Applications from drug companies should also include a commercial proposal, says Pharmac.
HealthZone supplements are made with the brand’s proprietary technologies: “Mineral Transporter” for targeted delivery of nutrients to specific parts of the body that need them most, and “Enzymatic Processing” to ensure the supplements can reboot the body to its default healthy state.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
New Zealand will likely be the next country to ban sales of popular OTC dry cough treatment pholcodine following a safety alert issued by the World Health Organization.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
New Zealand's Medicines Classification Committee has recommended expanded the dispensing conditions for AbbVie Inc.'s combination therapy for hepatitis C Maviret to include pharmacists who meet the requirements of the Pharmacy Council.
Legislation to significantly reform regulation of medicines and medical devices in New Zealand passed by parliament and will soon become law, but pharma and medtech industries have reservations about some provisions.
A bill that will significantly reform the regulation of medicines and medical devices in New Zealand has been passed by parliament and will soon become law, but the pharmaceutical and medtech industries have reservations about some of its provisions.
ADVERTISEMENT